| P2093 | author name string | J M Tréluyer | |
| | G Pons | |
| | E Rey | |
| | S Tonnelier | |
| | Y Merlé | |
| P2860 | cites work | Amikacin dosing in neonates: evaluation of a dosing chart based on population pharmacokinetic data | Q31126732 |
| | Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses: noncompartmental approach and compartmental modeling | Q32167611 |
| | Zidovudine pharmacokinetics in premature infants exposed to human immunodeficiency virus | Q33692439 |
| | Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity | Q33977062 |
| | Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients | Q34065956 |
| | Does the dose matter? | Q34347926 |
| | A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses | Q34389944 |
| | Pharmacokinetics and antibacterial activity of daily gentamicin | Q35066606 |
| | Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant | Q35248648 |
| | Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen | Q40794081 |
| | Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. | Q41058829 |
| | Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus | Q41184614 |
| | Once-daily dosing of aminoglycosides: review and recommendations for clinical practice | Q41530531 |
| | Pharmacokinetics of amikacin in infants and pre-school children | Q41598345 |
| | Once daily antibiotic regimen in paediatric oncology | Q42011952 |
| | Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients | Q42203007 |
| | Population pharmacokinetics of caffeine in premature neonates | Q42660188 |
| | Tobramycin population pharmacokinetics in neonates. | Q42666715 |
| | Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections | Q43552923 |
| | Population pharmacokinetics of gentamicin in neonates using a nonlinear, mixed-effects model | Q43640101 |
| | Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 |
| | Pharmacokinetic analysis of amikacin twice and single daily dosage in immunocompromised pediatric patients | Q44484329 |
| | Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit | Q44886328 |
| | Once versus twice daily amikacin in neonates: prospective study on toxicity | Q46381595 |
| | Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method | Q47428219 |
| | Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity | Q48390110 |
| | Determination of population pharmacokinetic parameters for amikacin in neonates using mixed-effect models. | Q50900607 |
| | Population pharmacokinetic modeling in very premature infants receiving midazolam during mechanical ventilation: midazolam neonatal pharmacokinetics. | Q51476018 |
| | Population pharmacokinetics of midazolam in neonates. | Q51617618 |
| | Population pharmacokinetic analysis of netilmicin in neonates and infants with use of a nonparametric method. | Q52076990 |
| | Modification in the pharmacokinetics of amikacin during development. | Q52434732 |
| | The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. | Q52695343 |
| | Pharmacokinetics of amikacin in neonates. | Q53732330 |
| | [Pharmacokinetics in neonates and infants following administration of amikacin]. | Q54135744 |
| | Influence of Intrauterine Maturation on the Pharmacokinetics of Amikacin in the Neonatal Period | Q61713352 |
| | Gentamicin dosage intervals in neonates: Longer dosage interval-less toxicity | Q61850443 |
| | Kinetics and dose calculations of amikacin in the newborn | Q67462285 |
| | Netilmicin in the neonate: population pharmacokinetic analysis and dosing recommendations | Q67919867 |
| | Gentamicin monitoring in neonates | Q67985938 |
| | Risk of renal dysfunction in critically ill trauma patients receiving aminoglycosides | Q69939087 |
| | Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine | Q70244570 |
| | Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia | Q70386358 |
| | Determination of a gentamicin loading dose in neonates and infants | Q70605602 |
| | Population kinetics of gentamicin in neonates | Q70693665 |
| | The accuracy of amikacin administration in neonates | Q71208599 |
| | Optimal gentamicin therapy in preterm neonates includes loading doses and early monitoring | Q71713124 |
| | Pharmacokinetics of once-a-day netilmicin (6 mg/kg) in neonates | Q71722519 |
| | Renal function in preterm neonates | Q72597330 |
| | Pharmacokinetics of once-daily dosing of gentamicin in neonates | Q73582979 |
| | Body water compartments in children: changes during growth and related changes in body composition | Q78841789 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| | amikacin | Q408529 |
| P304 | page(s) | 1381-1387 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children | |
| P478 | volume | 46 | |